Table 3.
Univariate and multivariate analysis predicting CEACAM6 overexpression in lung adenocarcinoma.
| Univariate | Multivariate | ||||
| OR (95% CI) | P-value* | OR (95% CI) | P-value* | ||
| Age | 1.3747 (0.5096–3.7082) | 0.5285 | – | – | |
| Gender | Male | Reference | – | – | |
| Female | 3.8889 X 103 (0–2.8085 X 1012) | 0.4259 | – | – | |
| Stage | I | Reference | – | – | |
| II | 0.2484(0–3.4530 X 1012) | 0.9278 | – | – | |
| III | 0.0011(0–7.7045 X 1013) | 0.7289 | – | – | |
| IV | 0 (0–8.0545 X 1025) | 0.2962 | – | – | |
| Smoking | Current smoker | Reference | Reference | ||
| Ex-smoker | 6.3226 X 1020 (8.1209 X 102–4.9225 X 1038) | 0.0228 | 6.5863 X 1019 (9.2860 X 10–4.6716 X 1037) | 0.0297 | |
| Non-smoker | 3.4659 X 1024 (4.2514 X 109–2.8255 X 1039) | 0.0013 | 5.1067 X 1021 (3.6028 X 106–7.2383 X 1036) | 0.0051 | |
| EGFR mutation | Wild | Reference | reference | ||
| Mutant | 1.7641 X 1011 (1.5211 X 102–2.0460 X 1020) | 0.0152 | 5.3840 X 108 (0.31110–9.3170 X 1017) | 0.0639 |
* P-value was obtained from linear regression.